Genomic information of the arsenic-resistant bacterium Lysobacter arseniciresistens type strain ZS79(T) and comparison of Lysobacter draft genomes

per Liu, Lin, Zhang, Shengzhe, Luo, Meizhong, Wang, Gejiao
Publicat a Stand Genomic Sci (2015)

Draft genome sequence of Cellulomonas carbonis T26(T) and comparative analysis of six Cellulomonas genomes

per Zhuang, Weiping, Zhang, Shengzhe, Xia, Xian, Wang, Gejiao
Publicat a Stand Genomic Sci (2015)

Global Regulator IscR Positively Contributes to Antimonite Resistance and Oxidation in Comamonas testosteroni S44

per Liu, Hongliang, Zhuang, Weiping, Zhang, Shengzhe, Rensing, Christopher, Huang, Jun, Li, Jie, Wang, Gejiao
Publicat a Front Mol Biosci (2015)

Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors

per Zhang, Shengzhe, Zhang, Meiying, Jing, Ying, Yin, Xia, Ma, Pengfei, Zhang, Zhenfeng, Wang, Xiaojie, Di, Wen, Zhuang, Guanglei
Publicat a Nat Commun (2018)

Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer

per Zhang, Shengzhe, Jing, Ying, Zhang, Meiying, Zhang, Zhenfeng, Ma, Pengfei, Peng, Huixin, Shi, Kaixuan, Gao, Wei-Qiang, Zhuang, Guanglei
Publicat a Sci Rep (2015)

PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors

per Shi, Kaixuan, Yin, Xia, Cai, Mei-Chun, Yan, Ying, Jia, Chenqiang, Ma, Pengfei, Zhang, Shengzhe, Zhang, Zhenfeng, Gu, Zhenyu, Zhang, Meiying, Di, Wen, Zhuang, Guanglei
Publicat a eLife (2019)

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1

per Zhang, Zhenfeng, Ma, Pengfei, Jing, Ying, Yan, Ying, Cai, Mei-Chun, Zhang, Meiying, Zhang, Shengzhe, Peng, Huixin, Ji, Zhi-Liang, Di, Wen, Gu, Zhenyu, Gao, Wei-Qiang, Zhuang, Guanglei
Publicat a Theranostics (2016)

Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase

per Dong, Jiang-Kai, Lei, Hui-Min, Liang, Qian, Tang, Ya-Bin, Zhou, Ye, Wang, Yang, Zhang, Shengzhe, Li, Wen-Bin, Tong, Yunguang, Zhuang, Guanglei, Zhang, Liang, Chen, Hong-Zhuan, Zhu, Liang, Shen, Ying
Publicat a Theranostics (2018)

Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum

per Dong, Jiang-Kai, Lei, Hui-Min, Liang, Qian, Tang, Ya-Bin, Zhou, Ye, Wang, Yang, Zhang, Shengzhe, Li, Wen-Bin, Tong, Yunguang, Zhuang, Guanglei, Zhang, Liang, Chen, Hong-Zhuan, Zhu, Liang, Shen, Ying
Publicat a Theranostics (2021)

Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer

per Ma, Pengfei, Fu, Yujie, Cai, Mei-Chun, Yan, Ying, Jing, Ying, Zhang, Shengzhe, Chen, Minjiang, Wu, Jie, Shen, Ying, Zhu, Liang, Chen, Hong-Zhuan, Gao, Wei-Qiang, Wang, Mengzhao, Gu, Zhenyu, Bivona, Trever G., Zhao, Xiaojing, Zhuang, Guanglei
Publicat a Nat Commun (2017)